Surveillance: 252 Real Stories

252 stories match surveillance. 199 of them mention surgery.

Andrea, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Andrea's Survivor Story

Patient Info: Andrea, Female, Under 40 | Stage III

As of May 2024, Andrea had completed radiation with continuous 5-FU, 8 intensive chemotherapy infusions, tumor surgery with temporary ileostomy, and ileostomy reversal; a liver-lesion scare was a false alarm and she was cancer-free.

The Patient Story
OutcomeCancer-Free / NED
Samantha, who was diagnosed with Breast CancerBreast Cancer

Triple-Negative Breast Cancer: Samantha's Survivor Story

Patient Info: Samantha Salway, Female, Under 40

Biomarkers: ER-negative; PR-negative; HER2-negative

As of May 2024, Samantha had delivered a healthy baby, completed chemotherapy, lumpectomy, radiation and additional chemotherapy, had no current evidence of cancer, and remained under close monitoring.

Cleveland Clinic
OutcomeCancer-Free / NED
Ed, who was diagnosed with Stage II Lung CancerLung Cancer

Stage II Lung Cancer: Ed's Survivor Story

Patient Info: Ed Ackerman, Male, 60s | Stage II

Follow-up tests and scans showed Ed was cancer-free after lung resection and 4 rounds of chemotherapy for Stage IIA lung cancer.

Cleveland Clinic
OutcomeCancer-Free / NED
Savannah, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Savannah's Survivor Story

Patient Info: Savannah Kaspar, Female, Under 40 | Stage II

Biomarkers: Lynch syndrome genetic testing negative

As of March 2024, Savannah had completed partial colectomy and 4 rounds of adjuvant chemotherapy for Stage II sigmoid colon cancer and had entered surveillance with bloodwork every 3 months.

MD Anderson
OutcomeSurvivorship / Surveillance
John, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: John's Survivor Story

Patient Info: John, Male, Under 40 | Stage II

As of March 2024, John had a complete response to chemotherapy and radiation for Stage II rectal cancer, with the tumor completely gone, no signs of cancer remaining, no surgery needed, and ongoing watch-and-wait monitoring.

Cleveland Clinic
OutcomeCancer-Free / NED
A patient, who was diagnosed with Invasive Ductal CarcinomaBreast Cancer

Early-stage breast cancer (DCIS) in a male patient

Patient Info: Anonymized, Male

He chose annual imaging surveillance of the remaining left breast after deferring chemoprevention.

PubMed Central
OutcomeSurvivorship / Surveillance
A patient, who was diagnosed with Colorectal AdenocarcinomaColorectal Cancer

Colon cancer recurrence at a surgical drain site

Patient Info: Anonymized, Male

He recovered well after abdominal-wall excision and was followed every 3–6 months, with no clinical signs of further recurrence or metastasis.

PubMed Central
OutcomeSurvivorship / Surveillance
Jason, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Jason Randall: stage IV colorectal cancer and liver metastases

Patient Info: Jason Randall, Male, Under 40 | Stage IV

Metastatic Site: Liver; lung; tailbone/sacrum/pelvis

As of March 2024, Jason was 2.5 years off chemotherapy and 16 months with no evidence of disease after treatment for Stage IV rectosigmoid colorectal cancer.

City of Hope
OutcomeCancer-Free / NED
Ivy, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV EGFR Lung Cancer: Ivy's Survivor Story

Patient Info: Ivy E., Female, 40s | Stage IV

Biomarkers: EGFR mutation

Metastatic Site: Bone: elbow, cervical spine/neck, rib, pelvis; brain

As of January 2024, Ivy reported no evidence of disease 1 year after right upper lobectomy, after years of response to EGFR-targeted therapy for initially Stage IV lung cancer.

The Patient Story
OutcomeCancer-Free / NED
Jelena, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jelena's Survivor Story

Patient Info: Jelena, Female, Under 40 | Stage III

As of January 2024, Jelena was on annual follow-up after Stage III rectal cancer treatment, with her latest colonoscopy showing no polyps or suspicious findings.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Colorectal Squamous Cell CarcinomaColorectal Cancer

Understanding rectal squamous cell carcinoma, a rare form of rectal cancer

Patient Info: Anonymized, Female

Biomarkers: SCC antigen 0.6 ng/mL at 6-month response assessment

A complete response was established at 6 months, and she remained without clinical, laboratory or imaging evidence of disease 2 years after treatment.

PubMed Central
OutcomeCancer-Free / NED
Deborah, who was diagnosed with Stage IV Lung CancerLung Cancer

Stage IV Lung Cancer: Deborah's Patient Story

Patient Info: Deborah Persinger, Female, 70+ | Stage IV

Metastatic Site: Brain

As of January 2024, Deborah was living actively 13 years after lung cancer diagnosis, with recurrent brain metastases managed through repeated Gamma Knife radiosurgery and ongoing MRI surveillance.

Cleveland Clinic
OutcomeLiving With Cancer
Jay, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Jay's Survivor Story

Patient Info: Jay McCoy, Male, 40s | Stage II

As of January 2024, Jay had made a full recovery after Stage II colon cancer was found early by colonoscopy and treated surgically, with normal numbers at his second annual physical in June 2023.

Cleveland Clinic
OutcomeSurvivorship / Surveillance
Jim, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Jim's Patient Story

Patient Info: Jim Bromwich, Male, Under 40 | Stage IV

Metastatic Site: Lung

As of January 2024, he had completed focused radiation to an isolated lung nodule and was awaiting follow-up scans; another tiny lung nodule was being monitored but was not PET-avid.

The Patient Story
OutcomeCare Ongoing
Chantal, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Chantal's Survivor Story

Patient Info: Chantal, Female, Under 40 | Stage II

Biomarkers: Triple-negative breast cancer; BRCA1 mutation

As of December 2023, Chantal reported that she did not currently have cancer, was followed by medical oncology every 3-4 months, and used Signatera testing because tumor markers were not reliable for her.

The Patient Story
OutcomeCancer-Free / NED
Stephanie, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Stephanie's Survivor Story

Patient Info: Stephanie, Female, Under 40 | Stage III

As of November 2023, Stephanie reported that her oncologist said her cancer was in remission after surgery and chemotherapy, with CT/lab follow-up and a PET scan for reassurance.

The Patient Story
OutcomeCancer-Free / NED
Debra, who was diagnosed with Stage I Lung CancerLung Cancer

Stage I Lung Cancer: Debra's Survivor Story

Patient Info: Debra Haberstroh, Female | Stage I

As of November 2023, Debra was 5 months after May 2023 lung tumor resection, did not need chemotherapy, was described by her oncologist as technically cured, and continued surveillance imaging.

Cleveland Clinic
OutcomeCancer-Free / NED
Barbara, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Barbara's Survivor Story

Patient Info: Barbara, Female, 40s | Stage III

As of November 2023, Barbara described herself as a colon cancer survivor in year 4 after surgery and chemotherapy, continuing surveillance scans and living with scan anxiety and lasting treatment effects.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Sherri, who was diagnosed with Stage IV Multiple primaries: metastatic Breast Cancer + Colon/Colorectal CancerMultiple primaries: metastatic Breast Cancer + Colon/Colorectal Cancer

Stage IV HER2-Positive Multiple primaries: metastatic Breast Cancer + Colon/Colorectal Cancer: Sherri's Patient Story

Patient Info: Sherri, Female | Stage IV

Biomarkers: HER2-positive breast cancer; colon cancer Signatera positive before surgery and negative after surgery

Metastatic Site: Bone marrow

As of October 2023, Sherri had no evidence of disease on recent scans for HER2-positive metastatic breast cancer but was receiving oxaliplatin/Oxyplatin chemotherapy and transfusions for a separate early Stage III colon cancer.

The Patient Story
OutcomeCare Ongoing
Shannon, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II MSI-High Colorectal Cancer: Shannon's Survivor Story

Patient Info: Shannon, Female, Under 40 | Stage II

Biomarkers: MSI-H; Lynch syndrome; MLH1 mutation

As of October 2023, Shannon had no recurrence described while approaching year 5 after Stage IIA colon cancer surgery and continued intensive Lynch syndrome surveillance.

The Patient Story
OutcomeCancer-Free / NED
Kelly, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III MSI-High Colorectal Cancer: Kelly's Survivor Story

Patient Info: Kelly, Female, Under 40 | Stage III

Biomarkers: dMMR; MSI-H

As of September 2023, Kelly remained in remission after 9 dostarlimab immunotherapy infusions for Stage III dMMR/MSI-H rectal cancer, avoiding the expected chemo/radiation/surgery pathway.

The Patient Story
OutcomeCancer-Free / NED